Researches

Displaying 161 - 170 of 4037
# Title Department Research Year
161 Design and synthesis of novel quinoline-ester/-amide derivatives as potent antiproliferative agent targeting EGFR and BRAFV600E kinases Department of Pharmaceutical Organic Chemistry 2024
162 Design, synthesis and mechanistic anticancer activity of new acetylated 5-aminosalicylate-thiazolinone hybrid derivatives Department of Pharmaceutical Organic Chemistry 2024
163 Design, synthesis, and antiproliferative activity of new 1, 2, 3-triazole/quinazoline-4-one hybrids as dual EGFR/BRAF V600E inhibitors Department of Pharmaceutical Organic Chemistry 2024
164 Design, synthesis, and antiproliferative activity of new indole/1,2,4-triazole/chalcone hybrids as EGFR and/or c-MET inhibitors Department of Pharmaceutical Organic Chemistry 2024
165 Design, synthesis, and apoptotic antiproliferative action of new 1,2,3-triazole/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors Department of Pharmaceutical Organic Chemistry 2024
166 Design, synthesis, and biological evaluation of novel quinoline-based EGFR/HER-2 dual-target inhibitors as potential antitumor agents Department of Pharmaceutical Organic Chemistry 2024
167 Design, synthesis, and molecular docking of novel 1,3, 4-triaryl pyrazole derivatives bearing methylsulfonyl moiety with anticancer activity through dual targeting CDK2 and COX-2 enzymes Department of Medicinal Chemistry 2024
168 Design, synthesis, biological evaluation and docking study of some new aryl and heteroaryl thiomannosides as FimH antagonists. Department of Pharmaceutical Organic Chemistry 2024
169 Developing a switch “OFF-ON” fluorescent probe for detection of melamine based on doubly-protected red emissive copper nanoclusters mediated by Hg2+ ions Department of Pharmaceutical Analytical Chemistry 2024
170 Development of an innovative turn-on fluorescent probe for targeted in-vivo detection of nitric oxide in rat brain extracts as a biomarker for migraine disease Department of Pharmaceutical Analytical Chemistry 2024